Form 13-F position report

GILEAD SCIENCES INC

Reported by GREAT LAKES ADVISORS LLC

GILD CUSIP 375558103 Manager CIK 0001078013

Reported 1,094,942 shares, up 25,321 (2.4%) from the prior quarter.

Reported value 20.8%; share count 2.4% vs. the prior quarter.

Added
% of reported 13F value 1.29% This manager · Q3 2026
Shares 1,094,942 Quarter-end amount reported
Reported value $163,201,627 Fair value at quarter end
Consecutive quarters held 9 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-03-31 3036000
2022-06-30 3056000
2022-09-30 0
2022-12-31 560772
2023-03-31 565855
2023-06-30 519452
2023-09-30 403852
2023-12-31 426923
2024-03-31 0
2024-09-30 41802234
2024-12-31 90632702
2025-03-31 114888959
2025-06-30 112256095
2025-09-30 112422901
2025-12-31 125466537
2026-03-31 151842327
2026-06-30 135136338
2026-09-30 163201627

Quarterly position history

How this manager's reported quarter-end position changed over time.

18 quarters
Quarterly reported position history for GILEAD SCIENCES INC held by GREAT LAKES ADVISORS LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 1,094,942 +25,321 (2.4%) 1.29% $163,201,627 2026-11-06
Q2 2026 Reduced 1,069,621 -19,866 (-1.8%) 1.03% $135,136,338 2026-08-10
Q1 2026 Added 1,089,487 +67,277 (6.6%) 1.26% $151,842,327 2026-05-12
Q4 2025 Added 1,022,210 +9,394 (0.9%) 1.02% $125,466,537 2026-02-12
Q3 2025 Added 1,012,816 +317 (0.0%) 0.94% $112,422,901 2025-11-03
Q2 2025 Reduced 1,012,499 -15,537 (-1.5%) 0.94% $112,256,095 2025-08-11
Q1 2025 Added 1,028,036 +46,844 (4.8%) 1.03% $114,888,959 2025-05-16
Q4 2024 Added 981,192 +482,597 (96.8%) 0.78% $90,632,702 2025-02-10
Q3 2024 New 498,595 +498,595 (0.0%) 0.35% $41,802,234 2024-11-04
Q1 2024 Reduced 0 -5,270 (-100.0%) 0 $0 2024-05-08
Q4 2023 Reduced 5,270 -119 (-2.2%) < 0.01% $426,923 2024-02-08
Q3 2023 Reduced 5,389 -1,351 (-20.0%) < 0.01% $403,852 2023-11-07
Q2 2023 Reduced 6,740 -80 (-1.2%) < 0.01% $519,452 2023-08-10
Q1 2023 Added 6,820 +288 (4.4%) < 0.01% $565,855 2023-05-10
Q4 2022 New 6,532 +6,532 (0.0%) 0.03% $560,772 2023-02-09
Q3 2022 Reduced 0 -49,444 (-100.0%) 0 $0 2022-11-09
Q2 2022 Reduced 49,444 -1,624 (-3.2%) 0.06% $3,056,000 2022-08-09
Q1 2022 New 51,068 +51,068 (0.0%) 0.05% $3,036,000 2022-05-06
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

2482 managers reported GILEAD SCIENCES INC for Q3 2026.

Managers reporting GILEAD SCIENCES INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 125,246,865 +3,402,757 0.27% $18,668,045,217 9 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 81,175,627 +83,893 0.25% $12,099,227,204 3 qtrs
STATE STREET CORPORATION Reduced 60,954,967 -261,585 0.26% $9,085,337,831 54 qtrs
FMR LLC Reduced 58,265,696 -8,605,120 0.37% $8,684,501,953 54 qtrs
Invesco Ltd Reduced 38,662,436 -1,156,715 0.45% $5,762,636,028 54 qtrs
Capital World Investors Reduced 35,929,833 -5,059,142 0.65% $5,355,872,692 54 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 35,685,818 +369,650 0.24% $5,318,971,173 3 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 30,190,640 +124,998 0.23% $4,485,711,723 54 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 27,664,121 -2,332,573 0.41% $4,123,338,000 54 qtrs
Capital Research Global Investors Added 23,980,766 +4,587,470 0.51% $3,574,341,919 54 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 06, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
128,639
Shared
0
None
3,104

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.